GBIO News and Press, Generation Bio Co. From 10/26/23

70% of circulating and splenic T cells positive for mRNA expression in humanized mice with less than 8% delivery to off-target immune cells Stealth properties of cell-targeted lipid nanoparticle (ctLNP) platform confirmed in non-human primates, demonstrating prolonged circulation an...

2023-10-23 08:31:36 ET Losers: Revolution Medicines ( RVMD ) -31% . Troika Media Group ( TRKA ) -21% . Li-Cycle Holdings Corp ( LICY ) -21% announces review of the rochester hub project . Mmtec ( MTC ) -18% . Palatin Technologies ( ...

2023-10-20 08:15:16 ET Lipella Pharmaceuticals ( LIPO ) +70% . Bowlero  ( BOWL ) +16% . Evolve Transition Infrastructure  ( SNMP ) +13% . Knight-Swift Transportation  ( KNX ) +12% Transportation Holdings Inc. (KNX) Q3 2023 Earni...

2023-10-19 13:58:05 ET More on Generation Bio Generation Bio: Novel But Preclinical, Interesting But Without Data Seeking Alpha’s Quant Rating on Generation Bio Historical earnings data for Generation Bio Financial information for Generation Bio ...

2023-10-19 10:00:13 ET More on Health Care Select Sector SPDR Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare (XLV) Stocks to watch in the Health Care sector as earnings close in BofA reports 10th consecutive week of equity inflows For further...

– Immune-quiet DNA (iqDNA) is a novel variant of closed-ended DNA (ceDNA) that evades host innate immune detection in both mice and non-human primates (NHPs) with a systemic cytokine profile and tolerability comparable to mRNA – Company is advancing iqDNA in lieu of p...

2023-09-22 15:00:17 ET More on the markets No Signs Of A Major Top Yet, Staying Long BofA strategists have changed their view of the S&P 500 target, up 4%. Quant stock news sentiment measure keeps improving - BofA Amazon, Disney, Boeing boosted in Wells F...

CAMBRIDGE, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will participate in ...

2023-09-07 17:10:58 ET Gainers: Smith & Wesson Brands  ( SWBI ) +11% . CymaBay Therapeutics ( CBAY ) +5% . DocuSign ( DOCU ) +5% . Ocular Therapeutix ( OCUL ) +4% . CorMedix  ( CRMD ) +4% . Losers: Altisourc...

2023-08-07 05:24:35 ET Summary Generation Bio is a global leader in non-viral DNA therapeutics, aiming to deliver lifelong genetic medicines on a disruptive scale. The company has three core technologies, including a high-capacity ceDNA construct and a ctLNP delivery system. G...